Zobrazeno 1 - 10
of 10
pro vyhledávání: '"J. M. Schattenberg"'
Autor:
L Kaps, C J Ahlbrand, R Gadban, M Nagel, C Labenz, P Klimpke, S Holtz, S Boedecker, M Michel, W M Kremer, M Hilscher, P R Galle, D Kraus, J M Schattenberg, J Weinmann-Menke
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0249342 (2021)
BackgroundADVanced Organ Support (ADVOS) is a novel type of extracorporeal albumin dialysis and holds promise to sustain liver function and recovery of patients with acute-on-chronic liver failure (ACLF). Previously, ADVOS was tested as continuous tr
Externí odkaz:
https://doaj.org/article/576f35213fdb4a41b82bb96c85c0a16b
Publikováno v:
Der Pathologe. 39(6)
Drug-induced liver injury is increasing, especially in elderly patients with polymedication and multimorbidity.Clinicopathologic correlation of immune-mediated liver injury, specifically liver injury following therapy with immune checkpoint inhibitor
Autor:
Y, Alt, J M, Schattenberg
Publikováno v:
Zeitschrift fur Gastroenterologie. 54(4)
Publikováno v:
Zeitschrift fur Gastroenterologie. 53(12)
Direct acting antivirals (DAAs) have increased cure rates for chronic hepatitis C infection up to nearly 100 %. At the same time treatment costs have risen significantly. Treating all HCV infected patients in Germany with DAAs would generate medicati
Autor:
E, Roeb, H M, Steffen, H, Bantel, U, Baumann, A, Canbay, M, Demir, U, Drebber, A, Geier, J, Hampe, C, Hellerbrand, A, Pathil-Warth, J M, Schattenberg, C, Schramm, H K, Seitz, N, Stefan, F, Tacke, A, Tannapfel, P, Lynen Jansen, J, Bojunga
Publikováno v:
Zeitschrift fur Gastroenterologie. 53(7)
Autor:
J, Weiss, M, Rau, H, Bantel, H, Bock, M, Demir, J, Kluwe, M, Krawczyk, A, Pathil-Warth, J M, Schattenberg, F, Tacke, E, Roeb, A, Geier, A, Zipprich
Publikováno v:
Zeitschrift fur Gastroenterologie. 53(6)
Non-alcoholic fatty liver disease (NAFLD) currently is one oft the most common reasons for chronic liver injury in the western world. In the European and American population the prevalence is up to 30 %. The medical supply of German patients with NAF
Autor:
V, Sivanathan, J M, Kittner, M F, Sprinzl, A, Weinmann, S, Koch, J, Wiltink, M, Nguyen-Tat, J U, Marquardt, M A, Wörns, T, Zimmermann, H, Lang, P R, Galle, J M, Schattenberg
Publikováno v:
Deutsche medizinische Wochenschrift (1946). 139(36)
Liver cirrhosis develops as a terminal complication of chronic liver disease. The clinical course is determined by the underlying etiology and the accompanying risk factors, which are influenced by the geographic and cultural background.A total of 23
Autor:
S, Rösner, A, Schad, J, Kittner, F, Rahman, M A, Wörns, M, Schuchmann, P R, Galle, J M, Schattenberg
Publikováno v:
Zeitschrift fur Gastroenterologie. 52(1)
Therapeutic agents to inhibit tumour necrosis factor alpha (TNF-α) have dramatically improved the treatment options for patients with autoimmune diseases. Common side effects include an increased susceptibility towards infection. Hepatic side effect
Autor:
J. Gawehn, Peter P. Urban, J. M. Schattenberg, Klaus Altland, S. Hägele, M. Wunsch, C. Hertkorn
Publikováno v:
Journal of Neurology. 253:1238-1240
Sirs: We report on a 31-year old woman with a known history of familial amyloidosis with the transthyretin (TTR) variant Leu12Pro. The pedigree can be traced back to the year 1780. For three years the patient had suffered from a primary partial secon
Publikováno v:
Praxis. 95(48)
Acute liver failure is a rare disease that can cause death in the majority of untreated cases. Sudden loss of liver function in the absence of a preexisting liver disease is considered the true form and has to be distinguished from impaired function